N K Arora

With the emergency of new COVID-19 variant 'Omicron', COVID-19 task force chairman Dr N K Arora said that a comprehensive policy on the booster and additional doses of COVID-19 vaccine will be announced in two weeks.

It took India a little over nine months to achieve the one billion vaccination milestone, but the next billion doses will only take about three to four months, said Dr NK Arora, who heads the National Expert Group on Vaccine Administration

The supply of Bharat Biotech's Covaxin has been slowed down because the first few batches at the company's newest facility in Bengaluru were not of the right quality, a top government adviser has said.

The Delta variant was primarily responsible for the second wave of COVID-19 in the country, accounting for over 80 per cent of new cases, Dr N K Arora, co-chair of Indian SARS-CoV-2 Genomics Consortium said, underlining that the cases may go up if a

The Delta plus variant of COVID-19 has greater affinity to lung tissues as compared to other strains but it does not mean that it will cause severe disease or is more transmissible, head of coronavirus working group Dr N K Arora said.

The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday.

Drones may soon be seen delivering vaccines and life-saving drugs in remote areas of the country, said N K Arora, Chairman, Covid working group and Chief, National Technical Advisory Group on Immunisation.

With the emergency of new COVID-19 variant 'Omicron', COVID-19 task force chairman Dr N K Arora said that a comprehensive policy on the booster and additional doses of COVID-19 vaccine will be announced in two weeks.

It took India a little over nine months to achieve the one billion vaccination milestone, but the next billion doses will only take about three to four months, said Dr NK Arora, who heads the National Expert Group on Vaccine Administration

The supply of Bharat Biotech's Covaxin has been slowed down because the first few batches at the company's newest facility in Bengaluru were not of the right quality, a top government adviser has said.

The Delta variant was primarily responsible for the second wave of COVID-19 in the country, accounting for over 80 per cent of new cases, Dr N K Arora, co-chair of Indian SARS-CoV-2 Genomics Consortium said, underlining that the cases may go up if a

The Delta plus variant of COVID-19 has greater affinity to lung tissues as compared to other strains but it does not mean that it will cause severe disease or is more transmissible, head of coronavirus working group Dr N K Arora said.

The decision regarding enhancing interval between two doses of Covishield was based on scientific evidence and taken in a transparent manner, NTAGI Chair N K Arora said on Tuesday.

Drones may soon be seen delivering vaccines and life-saving drugs in remote areas of the country, said N K Arora, Chairman, Covid working group and Chief, National Technical Advisory Group on Immunisation.